Cargando…

Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice

BACKGROUND: The detection of V600E BRAF mutation in melanoma is fundamental since here BRAF inhibitors represent an effective treatment. Non-V600E BRAF mutations that may also respond are not detected by certain screening methods. Thus, knowledge about detection of these mutations is needed. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinzerling, L, Kühnapfel, S, Meckbach, D, Baiter, M, Kaempgen, E, Keikavoussi, P, Schuler, G, Agaimy, A, Bauer, J, Hartmann, A, Kiesewetter, F, Schneider-Stock, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670489/ https://www.ncbi.nlm.nih.gov/pubmed/23579220 http://dx.doi.org/10.1038/bjc.2013.143

Ejemplares similares

Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
por: Heinzerling, L, et al.
Publicado: (2013)

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?
por: Heinzerling, L, et al.
Publicado: (2014)

NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma
por: Flockhart, R J, et al.
Publicado: (2009)

Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports
por: Schliep, Stefan, et al.
Publicado: (2018)

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
por: Seppälä, T T, et al.
Publicado: (2015)

BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias
por: Konishi, K, et al.
Publicado: (2006)

Multi-colour FISH in oesophageal adenocarcinoma—predictors of prognosis independent of stage and grade
por: Geppert, C-I, et al.
Publicado: (2014)

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2009)

BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy
por: Meckbach, Diana, et al.
Publicado: (2014)

Which melanoma patient carries a BRAF-mutation? A comparison of predictive models
por: Eigentler, Thomas, et al.
Publicado: (2016)

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
por: Dono, M, et al.
Publicado: (2014)

BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities
por: Peixoto, Renata D, et al.
Publicado: (2022)

Data-driven analysis to identify prognostic immune-related biomarkers in BRAF mutated cutaneous melanoma microenvironment
por: Huang, Biao, et al.
Publicado: (2022)

Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma
por: Soufir, N, et al.
Publicado: (2004)

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours
por: Özdağ, H, et al.
Publicado: (2002)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)
por: Wildner, Dane, et al.
Publicado: (2021)

Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients with Primary Melanoma
por: Meckbach, Diana, et al.
Publicado: (2014)

Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations
por: Deb, S, et al.
Publicado: (2014)

Strong reduction of AGO2 expression in melanoma and cellular consequences
por: Völler, D, et al.
Publicado: (2013)

Role of MC1R variants in uveal melanoma
por: Hearle, N, et al.
Publicado: (2003)

XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk
por: Baccarelli, A, et al.
Publicado: (2004)

Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications
por: Hultdin, M, et al.
Publicado: (2003)

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
por: Lesueur, F, et al.
Publicado: (2008)

Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma()()
por: Kim, Hee Kyung, et al.
Publicado: (2016)

Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma
por: Gremel, G, et al.
Publicado: (2011)

Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnostics
por: Wildhardt, Gabriele, et al.
Publicado: (2013)

Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas
por: Yoshimura, S, et al.
Publicado: (2003)

Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins
por: Barrett, J H, et al.
Publicado: (2003)

Removing Background Co-occurrences of Transcription Factor Binding Sites Greatly Improves the Prediction of Specific Transcription Factor Cooperations
por: Meckbach, Cornelia, et al.
Publicado: (2018)

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2
por: De Paola, F, et al.
Publicado: (2003)

A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma
por: Halsall, J A, et al.
Publicado: (2004)

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
por: Wang, Chen, et al.
Publicado: (2016)

MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project
por: Tagliabue, E, et al.
Publicado: (2015)

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours
por: Marian, C, et al.
Publicado: (2005)

O(6)-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma
por: Ma, S, et al.
Publicado: (2003)

Highly regulated, diversifying NTP-dependent biological conflict systems with implications for the emergence of multicellularity
por: Kaur, Gurmeet, et al.
Publicado: (2020)

Rare variants increase the risk of severe COVID-19
por: van de Veerdonk, Frank L, et al.
Publicado: (2021)

Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer
por: Jarvis, David, et al.
Publicado: (2016)

Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3
por: Hughes, S, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mgg8gud9n2ia5uob38b2msoilu